JESSICA DADGARI: Open Payments
NPI 1639715915 · ARGYLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,273 in 112 payments from 17 companies in 2025. Trend: 2023 $21 · 2024 $1,842 · 2025 $2,273
Food & beverage: $2,173Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $765 |
| Janssen Biotech, Inc. | 12 | $287 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $203 |
| Phathom Pharmaceuticals, Inc. | 9 | $185 |
| Madrigal Pharmaceuticals | 6 | $157 |
| PFIZER INC. | 13 | $139 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $112 |
| Ipsen Biopharmaceuticals, Inc | 4 | $103 |
| Lilly USA, LLC | 3 | $57 |
| Gilead Sciences, Inc. | 2 | $47 |
Products named: RINVOQ, SKYRIZI, TREMFYA, ENTYVIO, VOQUEZNA, REZDIFFRA, XIFAXAN, CREON.
Industry payments across TX — which companies pay providers there.
